Teen cancer survival rates on the rise
19 Aug 2008
The first national report detailing survival for teenagers and young adults with cancer shows that survival rates climbed by about 11% over two decades.
The University of Manchester findings, published in the British Journal of Cancer today (Tuesday), looked at survival across all cancers in people aged 13 to 24 between 1979 and 2001.
Previously, statistical information about cancers in people in this age group has been limited, as patients were treated as either a child or adult. Before now, the importance of classing young people as a separate group was not recognised.
It is now understood that the spectrum of cancers affecting young people is different from children and adults and their physical, social and educational needs are also unique.
This report, funded by Cancer Research UK, will serve as a baseline for monitoring and guiding health policy geared towards developing specialised cancer care for teenagers and young people.
Lead author, Professor Jillian Birch, director of Cancer Research UK’s Paediatric and Familial Cancer Research Group at The University of Manchester, said: “We found that survival for teenagers and young people with cancer improved overall from 63 per cent between 1979 and 1984 to 74 per cent between 1996 and 2001, which is great news. But more needs to be done to drive this figure even higher.
“It’s important that cancer services are tailored to suit teenagers and young adults, as their needs differ from older adults and children – clinically and psychologically. Research like this is needed to measure how much of an impact this tailored treatment could have.”
The researchers analysed five-year survival in more than 30,000 13 to 24 year olds diagnosed with cancer in England between 1979 and 2001, and followed them up to 2003.
The greatest increase in survival rates was seen for leukaemia, which increased by 21 per cent over the 23 years studied. But survival for brain tumours, bone cancers and soft tissue sarcomas hasn’t changed significantly since the mid-1980s.
Professor Birch added: “Our research has also identified cancers where survival rates remain poor, highlighting the need for continuing research in those areas to drive up survival.”
Dr Lesley Walker, director of cancer information at Cancer Research UK, said: “Research like this is vital if we are to measure the impact of changes to the way teenagers with cancer are treated. Recruiting more young people on to clinical trials – which has been a priority for childhood cancer – will help this.
“It’s important that this group of patients receive the most appropriate treatment, and Cancer Research UK will continue investing in research to work towards this goal.”
Notes for editors
Survival from cancer in teenagers and young adults in England, 1979–2003. Birch et al. British Journal of Cancer. 2008.
CLIC Sargent provided additional funding for this research.
British Journal of Cancer
The BJC is owned by Cancer Research UK. Its mission is to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made BJC one of the world's premier general cancer journals. www.bjcancer.com.
About Cancer Research UK
- Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
- Cancer Research UK carries out world-class research to improve understanding of the disease and find out how to prevent, diagnose and treat different kinds of cancer.
- Cancer Research UK ensures that its findings are used to improve the lives of all cancer patients.
- Cancer Research UK helps people to understand cancer, the progress that is being made and the choices each person can make.
- Cancer Research UK works in partnership with others to achieve the greatest impact in the global fight against cancer.
- For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org.
For further information contact:
British Journal of Cancer
T: 020 7061 8252
M: 07050 264 059 (out-of-hours duty press officer)
Faculty of Medical and Human Sciences
The University of Manchester
T: 0161 275 8383
M: 07717 881 563